MetaADEDB 2.0 @ LMMD
Actoplus met
(QQPUCHJKWMHONF-UHFFFAOYSA-N)
Structure
SMILES
CN(C(=N)N=C(N)N)C.CCc1ccc(nc1)CCOc1ccc(cc1)CC1SC(=O)NC1=O.Cl.Cl
Molecular Formula:
C23H33Cl2N7O3S
Molecular Weight:
558.524
Log P:
5.3489
Hydrogen Bond Acceptor:
11
Hydrogen Bond Donor:
6
TPSA:
185.08
CAS Number(s):
737811-27-7
Synonym(s)
1.
Actoplus met
External Link(s)
PubChem Compound9850722
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Pharmaceutical product complaintFAERS: 9US FAERS
2Blood glucose increasedFAERS: 6US FAERS
3Drug dispensing errorFAERS: 4US FAERS
4Chest PainFAERS: 3US FAERS
5Incorrect dose administeredFAERS: 3US FAERS
6Abdominal PainFAERS: 2US FAERS
7AngioedemaFAERS: 2US FAERS
8AstheniaFAERS: 2US FAERS
9Atrial FibrillationFAERS: 2US FAERS
10Back PainFAERS: 2US FAERS
11Bladder NeoplasmFAERS: 2US FAERS
12ChromaturiaFAERS: 2US FAERS
13Drug ineffectiveFAERS: 2US FAERS
14FatigueFAERS: 2US FAERS
15Intercepted medication errorFAERS: 2US FAERS
16Myocardial InfarctionFAERS: 2US FAERS
17NauseaFAERS: 2US FAERS
18SyncopeFAERS: 2US FAERS
19Weight decreasedFAERS: 2US FAERS
20Angina PectorisFAERS: 1US FAERS
21ArthralgiaFAERS: 1US FAERS
22Back disorderFAERS: 1US FAERS
23Benign Prostatic HyperplasiaFAERS: 1US FAERS
24Bladder transitional cell carcinoma metastaticFAERS: 1US FAERS
25Bladder transitional cell carcinoma stage IIFAERS: 1US FAERS
26Blood urine presentFAERS: 1US FAERS
27CardiomegalyFAERS: 1US FAERS
28Cataract operationFAERS: 1US FAERS
29Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
30Diabetes mellitus inadequate controlFAERS: 1US FAERS
31DisorientationFAERS: 1US FAERS
32DizzinessFAERS: 1US FAERS
33Drug prescribing errorFAERS: 1US FAERS
34DysuriaFAERS: 1US FAERS
35Feeling ColdFAERS: 1US FAERS
36FlatulenceFAERS: 1US FAERS
37Impaired work abilityFAERS: 1US FAERS
38Intercepted drug dispensing errorFAERS: 1US FAERS
39Joint Range of Motion DecreasedFAERS: 1US FAERS
40LethargyFAERS: 1US FAERS
41MyalgiaFAERS: 1US FAERS
42No adverse eventFAERS: 1US FAERS
43Nonspecific reactionFAERS: 1US FAERS
44Obesity surgeryFAERS: 1US FAERS
45OsteopeniaFAERS: 1US FAERS
46Peripheral swellingFAERS: 1US FAERS
47PresyncopeFAERS: 1US FAERS
48Product physical issueFAERS: 1US FAERS
49Product substitution issueFAERS: 1US FAERS
50Pulmonary FibrosisFAERS: 1US FAERS
51Renal Cell CarcinomaFAERS: 1US FAERS
52Respiratory arrestFAERS: 1US FAERS
53Stevens-Johnson SyndromeFAERS: 1US FAERS
54TheftFAERS: 1US FAERS
55TremorFAERS: 1US FAERS
56Trisomy 21FAERS: 1US FAERS
57Urinary tract infectionFAERS: 1US FAERS
58UrticariaFAERS: 1US FAERS
59Wrong drug administeredFAERS: 1US FAERS
60Wrong technique in drug usage processFAERS: 1US FAERS
61jaundiceFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.